Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RDN | FNF |
|---|---|---|
| Price | $34.11 | $39.08 |
| Change today | ▲ 1.82% | ▲ 0.21% |
| Market cap | $4.51B | $10.48B |
| Return, 3 months | -8.4% | -19.0% |
| Return, year to date | -3.1% | -26.0% |
| Return, 1 year | +1.4% | -25.4% |
| P/E (TTM) | 8.8 | 13.6 |
| P/B | 0.9 | 1.4 |
| P/E percentile vs own 5y | 80th | 42nd |
| Dividend yield | 2.99% | 5.27% |
| Revenue growth (YoY, latest qtr) | +92.6% | +11.0% |
| Net profit growth (YoY) | -18.3% | -5.8% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 32.6% | 5.2% |
| Return on equity | 11.5% | 10.1% |
| Analyst target vs. price | +27.8% | +38.2% |
| Analyst buy share | 80% | 67% |
| RSI (14) | 49 | 26 |
| 30-day volatility | 31.3% | 26.0% |
| Max drawdown, 1 year | -22.4% | -30.8% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
